First participant diagnosed with creutzfeldt-jakob disease in the population-based rotterdam study was classified with mild cognitive impairment

HIGHLIGHTS

• who: Hata Karamujić-Čomić and colleagues from the DepartmentUniversity Oxford, Oxford, UK have published the research work: First participant diagnosed with Creutzfeldt-Jakob disease in the population-based Rotterdam Study was classified with mild cognitive impairment, in the Journal: (JOURNAL) of 27/01/2021
• what: The authors report the first case diagnosed with sCJD who was enrolled in a population-­based cohort study and was classified as having mild cognitive impairment during the diagnostic workup for sCJD. sCJD is a fatal neurological disease with a large variety in symptom onset and progression.
• how . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.